Iridoids as a Potential Hepatoprotective Class: A Review.


Journal

Mini reviews in medicinal chemistry
ISSN: 1875-5607
Titre abrégé: Mini Rev Med Chem
Pays: Netherlands
ID NLM: 101094212

Informations de publication

Date de publication:
2023
Historique:
received: 01 04 2022
revised: 28 04 2022
accepted: 29 04 2022
pubmed: 18 8 2022
medline: 17 3 2023
entrez: 17 8 2022
Statut: ppublish

Résumé

Liver disease rates are gradually increasing over the years, becoming a severe public health problem. The indiscriminate use of drugs associated with a rich fat diet, high consumption of alcoholic beverages, and exposure to viral infections and lipid peroxidative products are considered the chief factors for developing hepatic disorders. Owing to the absence of reliable hepatoprotective drugs in the therapeutic arsenal, since they present a high incidence of adverse reactions and/or lack of efficacy in some cases, liver diseases are widely treated with medicinal plants. Among them are the plants producing iridoids, which are believed to be good remedies for liver disease due to their bitter taste. The hepatoprotective effect of iridoids and extracts, rich in these compounds, has been demonstrated, both in vitro and in vivo. This review aims to scrutinize the available literature related to the hepatoprotective activity of iridoids. The information was obtained from scientific databases (Science Direct, PubMed, Web of Science, Scopus, ACS Publications, Wiley Online Library) until December, 2021. A total of 63 hepatoprotective iridoids were found, including aucubin, catalpol and picroliv, a mixture of two iridoids. They are the target of a high number of studies, which revealed their protective action against different hepatotoxic agents and detailed action mechanisms.

Sections du résumé

BACKGROUND BACKGROUND
Liver disease rates are gradually increasing over the years, becoming a severe public health problem. The indiscriminate use of drugs associated with a rich fat diet, high consumption of alcoholic beverages, and exposure to viral infections and lipid peroxidative products are considered the chief factors for developing hepatic disorders. Owing to the absence of reliable hepatoprotective drugs in the therapeutic arsenal, since they present a high incidence of adverse reactions and/or lack of efficacy in some cases, liver diseases are widely treated with medicinal plants. Among them are the plants producing iridoids, which are believed to be good remedies for liver disease due to their bitter taste. The hepatoprotective effect of iridoids and extracts, rich in these compounds, has been demonstrated, both in vitro and in vivo.
OBJECTIVE OBJECTIVE
This review aims to scrutinize the available literature related to the hepatoprotective activity of iridoids.
METHODS METHODS
The information was obtained from scientific databases (Science Direct, PubMed, Web of Science, Scopus, ACS Publications, Wiley Online Library) until December, 2021.
RESULTS AND CONCLUSION CONCLUSIONS
A total of 63 hepatoprotective iridoids were found, including aucubin, catalpol and picroliv, a mixture of two iridoids. They are the target of a high number of studies, which revealed their protective action against different hepatotoxic agents and detailed action mechanisms.

Identifiants

pubmed: 35975865
pii: MRMC-EPUB-125499
doi: 10.2174/1389557522666220816130158
doi:

Substances chimiques

Iridoids 0
Plant Extracts 0
Antioxidants 0

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

452-479

Subventions

Organisme : FAPERGS
ID : Edital PG 02/2017- Processo 17/1025-6
Organisme : CAPES and CNPq
ID : Edital 01/2016 - Processo 406282/2016-1, PQ- Processo 307096/2017-3
Organisme : Departamento de Química Farmacológica y Toxicológica, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Santiago
ID : 8380000

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Raquel Bridi (R)

Departamento de Química Farmacológica y Toxicológica, Facultad de Ciências Químicas y Farmacéuticas, Universidad de Chile, Santiago, 8380000, Chile.

Gilsane Lino von Poser (GL)

Laboratório de Farmacognosia, Programa de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul, 90610-000, Porto Alegre/RS, Brazil.

Gabriela de Carvalho Meirelles (G)

Laboratório de Farmacognosia, Programa de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul, 90610-000, Porto Alegre/RS, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH